Breaking News Instant updates and real-time market news.

IQV

Iqvia

$97.82

-1.31 (-1.32%)

20:12
05/17/18
05/17
20:12
05/17/18
20:12

Iqvia backs Q2 EPS view of $1.17-$1.24, consensus $1.26

Backs Q2 revenue view $2.47B-$2.52B, consensus $2.50B.

  • 16

    May

IQV Iqvia
$97.82

-1.31 (-1.32%)

05/16/18
BARD
05/16/18
NO CHANGE
Target $109
BARD
Neutral
Iqvia quality issues 'more than just a small overhang,' says Baird
Baird analyst Eric Coldwell says that while his initial thought upon hearing of the data quality issues was buy the weakness in Iqvia shares, he now feels the news represents "more than just a small overhang." The FDA data quality issue is a "new risk and all the potential ramifications will take some time to digest," Coldwell tells investors in an intraday research note. Iqvia is well off the day's lows but remains down 4.6% to $97.43 in afternoon trading. Coldwell has a Neutral rating on the shares with a $109 price target. He points out that FDA Commissioner Gottlieb is calling for Iqvia to immediately retain an auditor to review the controlled substance data and separately retain a third party to do an independent audit of data and process quality for all of its products used by the agency.
05/16/18
STFL
05/16/18
NO CHANGE
Target $128
STFL
Buy
Cost, scope of FDA requested audit key questions for Iqvia, says Stifel
After the FDA reported its scientists found inaccurate data items provided to the agency by an Iqvia database and requested the company hire an independent third party auditor to review the data quality and control procedures of all Iqvia products used by the agency, Stifel analyst Shlomo Rosenbaum said it is tough to gauge the potential magnitude and impact of the news. He sees the cost of an audit and the issue of whether the scope of the audit could be significantly expanded as the key questions. While stating that "the optics of the situation are not ideal," Rosenbaum is maintaining a Buy rating and $128 price target on Iqvia shares.
05/17/18
MZHO
05/17/18
NO CHANGE
Target $97
MZHO
Neutral
Iqvia data issues 'likely just a hiccup,' says Mizuho
Mizuho analyst Ann Hynes believes the data issues brought up yesterday by the FDA are "likely just a hiccup" for Iqvia. The analyst feels comfortable that the issue does not have ramifications on a significant portion of Iqvia's business, and that the issue has been resolved. She reiterates a Neutral rating on the shares with a $97 price target.
05/17/18
WBLR
05/17/18
NO CHANGE
WBLR
Outperform
Iqvia data issues only 'minor fundamental risk,' sayst William Blair
William Blair analyst John Kreger views the FDA's "stern rebuke" of Iqvia's data quality as a "moderate public relations problem for the company." From a fundamental standpoint, the analyst does not see the "episode turning into a demand or cost problem." Iqvia's data streams are often adjusted after the fact as more information becomes available, Kreger tells investors in a research note. As such, he thinks the vast majority of the company's biopharmaceutical clients would not be surprised or alarmed by such changes in the data set. The analyst keeps an Outperform rating on the shares, viewing yesterday's developments as only a "minor fundamental risk."

TODAY'S FREE FLY STORIES

CBRL

Cracker Barrel

$143.77

-6.93 (-4.60%)

06:30
09/19/18
09/19
06:30
09/19/18
06:30
Recommendations
Cracker Barrel analyst commentary  »

Cracker Barrel needs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BABA

Alibaba

$156.64

-2.12 (-1.34%)

06:30
09/19/18
09/19
06:30
09/19/18
06:30
Periodicals
China's Alibaba to set up dedicated chip subsidiary, Reuters reports »

Alibaba is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

ABUS

Arbutus Biopharma

$9.55

0.25 (2.69%)

06:30
09/19/18
09/19
06:30
09/19/18
06:30
Conference/Events
Arbutus Biopharma management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

BABA

Alibaba

$156.64

-2.12 (-1.34%)

06:26
09/19/18
09/19
06:26
09/19/18
06:26
Recommendations
Alibaba analyst commentary  »

Alibaba Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

ARPO

Aerpio Pharmaceuticals

$3.77

0.155 (4.29%)

06:26
09/19/18
09/19
06:26
09/19/18
06:26
Initiation
Aerpio Pharmaceuticals initiated  »

Aerpio Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

BK

BNY Mellon

$51.45

0.23 (0.45%)

06:26
09/19/18
09/19
06:26
09/19/18
06:26
Hot Stocks
KPMG admits misconduct on BNY Mellon reports, says watchdog »

The Financial Reporting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 18

    Oct

RNSDF

Renault

$0.00

(0.00%)

, VLKAY

Volkswagen

$0.00

(0.00%)

06:25
09/19/18
09/19
06:25
09/19/18
06:25
Periodicals
Renault, VW, Fiat Chrysler sales surged before new emissions test, Reuters says »

Renault (RNSDF),…

RNSDF

Renault

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

FCAU

Fiat Chrysler

$17.62

0.17 (0.97%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$87.33

-6.44 (-6.87%)

06:23
09/19/18
09/19
06:23
09/19/18
06:23
Syndicate
Argenx 3.48M share Secondary priced at $86.50 »

Morgan Stanley, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Sep

NFLX

Netflix

$367.85

17.61 (5.03%)

06:23
09/19/18
09/19
06:23
09/19/18
06:23
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:23
09/19/18
09/19
06:23
09/19/18
06:23
Hot Stocks
NY Attorney General: Cryptocurrency exchanges lack integrity, security, fairness »

New York Attorney General…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REVB

Revere Bank

$0.00

(0.00%)

06:20
09/19/18
09/19
06:20
09/19/18
06:20
Syndicate
Revere Bank 1.4M share Secondary priced at $29.25 »

Sandler ONeill acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GTHX

G1 Therapeutics

$62.94

-3.41 (-5.14%)

06:20
09/19/18
09/19
06:20
09/19/18
06:20
Syndicate
G1 Therapeutics 3M share Secondary priced at $60.00 »

JPMorgan and Cowen acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Sep

NVS

Novartis

$85.03

-0.1 (-0.12%)

06:18
09/19/18
09/19
06:18
09/19/18
06:18
Hot Stocks
Novartis' Kymriah for adult lymphoma 'to expensive to recommend,' says NICE »

The U.K.'s National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CNC

Centene

$142.82

1.055 (0.74%)

06:17
09/19/18
09/19
06:17
09/19/18
06:17
Initiation
Centene initiated  »

Centene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 23

    Oct

  • 14

    Dec

GM

General Motors

$35.11

0.09 (0.26%)

, TSLA

Tesla

$284.88

-9.9 (-3.36%)

06:17
09/19/18
09/19
06:17
09/19/18
06:17
Periodicals
Former GM exec Lutz says Tesla is 'headed for the graveyard', CNBC reports »

Bob Lutz, former vice…

GM

General Motors

$35.11

0.09 (0.26%)

TSLA

Tesla

$284.88

-9.9 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

AAPL

Apple

06:14
09/19/18
09/19
06:14
09/19/18
06:14
Recommendations
Apple analyst commentary  »

Apple offers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

, IQ

iQIYI

$26.29

-0.54 (-2.01%)

06:14
09/19/18
09/19
06:14
09/19/18
06:14
Periodicals
Tencent Music cuts size of U.S. IPO to $2B, Reuters reports »

Chinese music-streaming…

TCEHY

Tencent

$0.00

(0.00%)

IQ

iQIYI

$26.29

-0.54 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$11.93

0.335 (2.89%)

, RDC

Rowan Companies

$16.25

0.56 (3.57%)

06:13
09/19/18
09/19
06:13
09/19/18
06:13
Upgrade
Transocean, Rowan Companies, Ensco, Noble Corp. rating change  »

Transocean upgraded to…

RIG

Transocean

$11.93

0.335 (2.89%)

RDC

Rowan Companies

$16.25

0.56 (3.57%)

ESV

Ensco

$7.40

0.28 (3.93%)

NE

Noble Corp.

$6.15

0.19 (3.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SIR

Select Income REIT

$20.53

-1.18 (-5.44%)

06:13
09/19/18
09/19
06:13
09/19/18
06:13
Upgrade
Select Income REIT rating change  »

Select Income REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RFP

Resolute Forest

$14.65

0.125 (0.86%)

06:12
09/19/18
09/19
06:12
09/19/18
06:12
Downgrade
Resolute Forest rating change  »

Resolute Forest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$109.55

0.18 (0.16%)

06:11
09/19/18
09/19
06:11
09/19/18
06:11
Periodicals
Marvel heroes to get own TV series on Disney streaming service, Variety reports »

Disney is in early…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MCD

McDonald's

$157.77

-0.38 (-0.24%)

06:10
09/19/18
09/19
06:10
09/19/18
06:10
Hot Stocks
EU says McDonald's, Luxembourg tax deal not illegal »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ETFC

E-Trade

$53.77

0.46 (0.86%)

06:08
09/19/18
09/19
06:08
09/19/18
06:08
Upgrade
E-Trade rating change  »

E-Trade upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBC

Wabco

$114.86

-0.6 (-0.52%)

06:07
09/19/18
09/19
06:07
09/19/18
06:07
Recommendations
Wabco analyst commentary  »

Wabco target lowered to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 06

    Nov

FB

Facebook

$160.31

-0.29 (-0.18%)

06:05
09/19/18
09/19
06:05
09/19/18
06:05
Periodicals
Facebook pressed banks for ability to use financial data for ads, WSJ reports »

As recently as last year,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.